Interpreting, analysing and modelling COVID-19 mortality data
暂无分享,去创建一个
[1] B. Canard,et al. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade , 2020, Antiviral Research.
[2] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[3] Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China , 2020, Nature Medicine.
[4] Didier Sornette,et al. Predictability of catastrophic events: Material rupture, earthquakes, turbulence, financial crashes, and human birth , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[5] Matthew S. Miller,et al. Age-Specific Mortality During the 1918 Influenza Pandemic: Unravelling the Mystery of High Young Adult Mortality , 2013, PloS one.
[6] Min Kang,et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients , 2020, The New England journal of medicine.
[7] D. Mathieu,et al. High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) Requiring Invasive Mechanical Ventilation , 2020, Obesity.
[8] P. Vollmar,et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany , 2020, The New England journal of medicine.
[9] Gerardo Chowell,et al. Global Mortality Impact of the 1957–1959 Influenza Pandemic , 2016, The Journal of infectious diseases.
[10] Lei Liu,et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China , 2020, Diabetes Care.
[11] M. Nöthen,et al. Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event , 2020 .
[12] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.
[13] Minah Park,et al. A Systematic Review of COVID-19 Epidemiology Based on Current Evidence , 2020, Journal of clinical medicine.
[14] Chonggang Xu,et al. High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2 , 2020, Emerging infectious diseases.
[15] Carl A. B. Pearson,et al. The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study , 2020, The Lancet Public Health.
[16] Caetano Souto-Maior,et al. Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold , 2020, medRxiv.
[17] D. Sornette,et al. Generalized logistic growth modeling of the COVID-19 outbreak in 29 provinces in China and in the rest of the world , 2020, medRxiv.
[18] Eun Ji Kim,et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.
[19] Big hopes for big data , 2020, Nature Medicine.
[20] R. Busse,et al. Regulating entrepreneurial behaviour in European health care systems , 2002 .
[21] A. Walls,et al. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.
[22] P. Brennan,et al. Susceptibility-adjusted herd immunity threshold model and potential R0 distribution fitting the observed Covid-19 data in Stockholm , 2020, medRxiv.
[23] S. Bhatt,et al. Report 13: Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries , 2020 .
[24] E. Lau,et al. Effect of changing case definitions for COVID-19 on the epidemic curve and transmission parameters in mainland China: a modelling study , 2020, The Lancet Public Health.
[25] W. Ko,et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges , 2020, International Journal of Antimicrobial Agents.
[26] Navot Israeli,et al. Computational irreducibility and the predictability of complex physical systems. , 2003, Physical review letters.
[27] N. Banholzer,et al. Impact of non-pharmaceutical interventions on documented cases of COVID-19 , 2020, medRxiv.
[28] Shaojun Dai,et al. A high-quality genome sequence of alkaligrass provides insights into halophyte stress tolerance , 2020, Science China Life Sciences.
[29] C. Whittaker,et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis , 2020, The Lancet Infectious Diseases.
[30] W. Wei,et al. Presymptomatic Transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[31] Juan B. Gutierrez,et al. A Model Describing COVID-19 Community Transmission Taking into Account Asymptomatic Carriers and Risk Mitigation , 2020 .
[32] A nicotinic hypothesis for Covid-19 withpreventive and therapeutic implications , 2020 .
[33] S. Kitayama,et al. Mandated Bacillus Calmette-Guérin (BCG) vaccination predicts flattened curves for the spread of COVID-19 , 2020, Science Advances.
[34] J. Rocklöv,et al. The reproductive number of COVID-19 is higher compared to SARS coronavirus , 2020, Journal of travel medicine.
[35] W. Gardner,et al. The Coronavirus and the Risks to the Elderly in Long-Term Care , 2020, Journal of aging & social policy.
[36] Anna Stachel,et al. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[37] Hannah R. Meredith,et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application , 2020, Annals of Internal Medicine.
[38] K. Bhaskaran,et al. OpenSAFELY: factors associated with COVID-19 death in 17 million patients , 2020, Nature.
[39] G. Chowell,et al. The COVID-19 pandemic in the USA: what might we expect? , 2020, The Lancet.
[40] T. Meunier. Full lockdown policies in Western Europe countries have no evident impacts on the COVID-19 epidemic. , 2020, medRxiv.
[41] Holger Moch,et al. Endothelial cell infection and endotheliitis in COVID-19 , 2020, The Lancet.
[42] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[43] Amber C. Donahue,et al. Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial , 2020, Nature Medicine.
[44] L. D. Prins,et al. Original Paper: Home visits in Belgium: a multivariate analysis , 1999 .
[45] N. Linton,et al. Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data , 2020, medRxiv.
[46] A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications. , 2020, Comptes rendus biologies.
[47] J. Ioannidis,et al. COVID-19 antibody seroprevalence in Santa Clara County, California , 2020, medRxiv.
[48] S. Kirov. Association Between BCG Policy is Significantly Confounded by Age and is Unlikely to Alter Infection or Mortality Rates , 2020, medRxiv.
[49] D. Sornette. Critical Phenomena in Natural Sciences: Chaos, Fractals, Selforganization and Disorder: Concepts and Tools , 2000 .
[50] Jian-ming Wang,et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China , 2020, Science China Life Sciences.
[51] R. Szigeti,et al. BCG protects against COVID-19? A word of caution , 2020, medRxiv.
[52] A. Heald,et al. LIVING WITH COVID-19: BALANCING COSTS AGAINST BENEFITS IN THE FACE OF THE VIRUS , 2020, National Institute Economic Review.
[53] J. Low,et al. Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore. , 2020, JAMA.
[54] Yhu-Chering Huang,et al. Are children less susceptible to COVID-19? , 2020, Journal of Microbiology, Immunology and Infection.
[55] D. Wang,et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status , 2020, Military Medical Research.
[56] R. Neher,et al. Potential impact of seasonal forcing on a SARS-CoV-2 pandemic , 2020, medRxiv.
[57] Debashree Ray,et al. Differential COVID-19-attributable mortality and BCG vaccine use in countries , 2020, medRxiv.
[58] W. Dietz,et al. Obesity and its Implications for COVID‐19 Mortality , 2020, Obesity.
[59] K. Leder,et al. Zika among international travelers presenting to GeoSentinel sites, 2012-2019: implications for clinical practice. , 2020, Journal of travel medicine.
[60] Johannes Zierenberg,et al. Inferring change points in the spread of COVID-19 reveals the effectiveness of interventions , 2020, Science.
[61] E. Holmes,et al. The proximal origin of SARS-CoV-2 , 2020, Nature Medicine.
[62] S. Cauchemez,et al. Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature , 2014, BMC Infectious Diseases.
[63] S. Blower,et al. Modeling influenza epidemics and pandemics: insights into the future of swine flu (H1N1) , 2009, BMC medicine.
[64] Jacob B. Aguilar,et al. Investigating the Impact of Asymptomatic Carriers on COVID-19 Transmission , 2020, medRxiv.
[65] C. Vardavas,et al. COVID-19 and smoking: A systematic review of the evidence , 2020, Tobacco induced diseases.